ALPATH
AI-based Detection System for Cancer
Health Tech & Life Sciences
Non Active, Jun 2020 ceased to operate
Company Overview
Snapshot
Founded in October 2017 by Roi Ram, ALPATH operated with 1–10 employees. The company ceased operations in June 2020.
Business overview
ALPATH develops an AI-based solution designed to assist pathologists in their daily workflow, aiming to enhance productivity, reduce diagnostic errors, and recommend suitable treatments for cancer patients. The company's core technology focuses on quickly and automatically generating high-performance image detection algorithms, which are crucial for pathology. ALPATH serves pathology labs, with a business model targeting B2B and B2G markets within the Health Tech & Life Sciences sector, specifically in Digital Healthcare and Digital Medical Diagnostics.
Log in to access full profile ›Company Intelligence Q&A
- What is ALPATH's primary focus?
- ALPATH focuses on developing an AI-based detection system for cancer, aiming to improve pathology workflows and patient outcomes.
- When was ALPATH founded?
- ALPATH was founded in October 2017.
- What is ALPATH's operational status?
- ALPATH ceased to operate in June 2020.
- Who founded ALPATH?
- ALPATH was founded by Roi Ram.
- What markets does ALPATH target with its solutions?
- ALPATH targets B2B and B2G markets, providing solutions for pathology labs, insurance companies, and health organizations.